These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2801572)

  • 21. Coronary and systemic hemodynamic effects of nicardipine.
    Lambert CR; Hill JA; Nichols WW; Feldman RL; Pepine CJ
    Am J Cardiol; 1985 Mar; 55(6):652-6. PubMed ID: 3976506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
    Rodrigues EA; Lahiri A; Raftery EB
    Eur Heart J; 1987 Jun; 8(6):624-9. PubMed ID: 3622543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intravenous and intracoronary nicardipine.
    Lambert CR; Pepine CJ
    Am J Cardiol; 1989 Oct; 64(15):8H-15H. PubMed ID: 2801574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
    Drieu la Rochelle C; Berdeaux A; Richard V; Giudicelli JF
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):904-10. PubMed ID: 1725905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of atenolol in patients with coronary artery disease.
    Robinson C; Jackson G; Fisk C; Jewitt D
    Br Heart J; 1978 Jan; 40(1):22-8. PubMed ID: 341928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dobutamine stress testing in chronic heart failure--dose-response effects assessed by echo-Doppler.
    Guy S; Silke B
    Postgrad Med J; 1991; 67 Suppl 1():S62-7; discussion S68. PubMed ID: 1924081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.
    Burlew BS; Gheorghiade M; Jafri SM; Goldberg AD; Goldstein S
    Am Heart J; 1987 Oct; 114(4 Pt 1):793-804. PubMed ID: 3310565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
    Rapola JM; Pellinen TJ; Toivonen L; Nieminen MS
    Ann Med; 1990; 22(4):221-4. PubMed ID: 2248757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.
    Silke B; Verma SP; Nelson GI; Hussain M; Taylor SH
    Br J Clin Pharmacol; 1984 Nov; 18(5):717-24. PubMed ID: 6508981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group.
    Chest; 1991 Feb; 99(2):393-8. PubMed ID: 1989801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Feldman RL; Prida XE; Lambert CR; Hill JA
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):355-61. PubMed ID: 3155428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
    Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
    Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting.
    van Wezel HB; Koolen JJ; Visser CA; Dijkhuis JP; Vergroesen I; Moulijn AC; Deen L
    Am J Cardiol; 1989 Oct; 64(15):22H-27H. PubMed ID: 2679035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.
    Rocha P; Guerret M; David D; Marchand X; Kahn JC
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1525-32. PubMed ID: 2081146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
    Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
    Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
    Silke B; Verma SP; Hussain M; Jackson NC; Hafizullah M; Reynolds G; Taylor SH
    Herz; 1985 Apr; 10(2):112-9. PubMed ID: 3872835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioselective beta-blockade with atenolol and acebutolol following acute myocardial infarction: a multiple-dose haemodynamic comparison.
    Frais MA; Silke B; Ahuja RC; Verma SP; Nelson GI; Taylor SH
    J Cardiovasc Pharmacol; 1985; 7(1):80-5. PubMed ID: 2580155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular adaptation to orthostatic stress during vasodilator therapy.
    Lipsitz LA; Connelly CM; Kelley-Gagnon M; Kiely DK; Abernethy D; Waksmonski C
    Clin Pharmacol Ther; 1996 Oct; 60(4):461-71. PubMed ID: 8873694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.